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CHAPTER 9. WHAT CAN I KNOW?
The reader may be somewhat puzzled by this chapter because it is a philosophical
essay rather than a biomedical scientiﬁc discussion as traditionally seen in PhD
theses in our ﬁeld. In this essay, reasoning will question many assumptions that
are taken for granted in biomedical scientiﬁc practice. For example, the assumption
that you can see material things through the microscope is false, because what in
fact is seen are the reﬂections of such things [391][p.105]. In this chapter I will
investigate the foundation of the scientiﬁc knowledge produced regarding the DNA
sequence and name what we do observe in NGS analysis. The debate on the relation
between representation and the real things represented has been ongoing at least
since Plato’s allegory of the cave [293], and there are many diﬀerent conceptions in
current philosophical debate on scientiﬁc representation[117]. This chapter is not
meant to give full insight into the diﬀerent views present in current debate, but rather
to reﬂect on the epistemological status of NGS-based DNA analysis. In other words:
what is the justiﬁcation of our beliefs regarding the knowledge obtained through such
analysis? Here, as a catalyst for my reﬂection, I use one of those conceptions, the
‘constructive empiricism’ theory as posed by Bas van Fraassen in his book Scientiﬁc
Representation [391]. In van Fraassen’s anti-realist view, a scientiﬁc theory does
not make truth claims about reality or unobservables (that what is not perceivable
by humans using unaided senses [57]), but aims to produce empirically adequate
theories to shape our beliefs [247]. Constructive empiricism combines the elements
‘constructivism’ and ‘empiricism’. The ﬁrst of these notions was conceived by Bruno
Latour, and entails that we have a ‘slow and progressive access to objectivity’ [197],
in which this access can be obtained through well-designed scientiﬁc experiments.
The second term focuses on the process used that is based upon experiments and
observation. The answer to the question ‘What can I know?’, as presented in this
section, should be read from the perspective of this anti-realist view. In my opinion
this constructive empiricist view gives the fairest picture of science, enabling us to
believe theories to be true, while not obligating us to claim to have knowledge about
the unobservable.
I invite the reader to follow me in this reﬂection on the foundations of the
knowledge produced through DNA analysis and to join in the search for what is the
true subject of our analyses to see if we can form an accurate representation of the
DNA sequence through our measurements.
9.1 Perspectives and measurements
In Scientiﬁc Representation, van Fraassen investigates what representation is and
what its role is in science. He states that ‘[d]etection by means of instruments
is to be distinguished from observation, in the sense in which I use that term:
observation is perception, and perception is something possible for us, if at all,
without instruments’[p.93]. Instead, the material to observe and our perception
are mediated by a measurement and a measurement outcome. This measurement
outcome shows not what the object is like “in itself” but what it “looks like” in that
measurement setup. The user of the measurement instrumentation must express
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9.1. PERSPECTIVES AND MEASUREMENTS
the outcome in a judgment of the form “that is how it is from here”’[p.92]. In
genetics, the goal is to analyze genetic material such as DNA. However, we have
never seen DNA, except perhaps as a slimy white substance. Instead we use various
instruments, such as microscopes, gel electroforesis apparatus and sequencers, to
create reﬂections of chromosomes, bands on a gel or ﬂuorescent signals. Each
of these instruments performs some kind of measurement and gives us a diﬀerent
perspective on DNA. Subsequently, the measurement outcomes produced can then
be interpreted. In next-generation sequencing (NGS), for instance, the Illumina
instrument detects a ﬂuorescent signal produced during a chemical reaction. These
signals are transformed to images by a computer, and this is the ﬁrst part of the
analysis that can be perceived. In practice, computers further transform these images
to create so-called fastq ﬁles, which contain the sequence reads accompanied by
quality information to account for sequencing errors. These fastq ﬁles are often
termed ‘raw data’, but are in fact the measurement outcome. At this point – during
data analysis – new perspectives can be taken on the data stored in the fastq ﬁles,
giving diﬀerent measurement outcomes. Among these, as described in this thesis, are
SNV and indels, Copy Number Variations (CNVs), aneuploidies and translocations.
An important issue to consider at this point is what Ludvig Wittgenstein called
the logical space, meaning that each proposition has a truth-value corresponding to
a certain state of aﬀairs in the world and that there is a logical connection between
the propositions. Wittgenstein states that:
It would, so to speak, appear as an accident, when to a thing that could
exist alone on its own account, subsequently a state of aﬀairs could be made
to ﬁt.
If things can occur in atomic facts, this possibility must already lie in them.
(A logical entity cannot be merely possible. Logic treats of every possibility,
and all possibilities are its facts.)
Just as we cannot think of spatial objects at all apart from space, or temporal
objects apart from time, so we cannot think of any object apart from the
possibility of its connexion with other things.
If I can think of an object in the context of an atomic fact, I cannot think
of it apart from the possibility of this context. [422][2.0121]
Van Fraassen states that ‘[t]he act of measurement is an act – performed in ac-
cordance with certain operational rules – of locating an item in a logical space’
[391][p.165]. The logical space in DNA analysis not only consists of biological con-
nections, such as the connection with protein sequences and RNA expression, but
also within the measurement and analysis. In both cases there is some degree of
circularity based on assumptions of knowledge of the state of aﬀairs of the human
genome. Probes and primers are designed based on sequences on or around the
genomic region of interest. At least, it is assumed that they are. Therefore, the
measurement outcome can only be interpreted in context of the experimental set-up.
At ﬁrst sight this paragraph may seem to give a disturbing message. If we are
not analyzing DNA, but rather measurement outcomes, what is the epistemologi-
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CHAPTER 9. WHAT CAN I KNOW?
cal status of the results of our genetic analyses? In my opinion, for large parts of
the genome, it is justiﬁed to believe that NGS analysis is able to give an accurate
representation of the DNA sequence. This I base on the fact that representations
produced by NGS pass the coherence constraint [p.152], meaning that there is an
internal and external coherence between measurements. NGS seems to pass this
criterion. Given suﬃcient quality, subsequent measurements and analyses using the
same machine have a high concordance. Importantly, there is also high concor-
dance between NGS platforms, although all platforms have diﬀerent strong and
weak points [309] and each type of sample preparation and sequencing platform is
prone to certain types of bias [3, 315]. Because the diﬀerent platforms use diﬀerent
sample preparation techniques and diﬀerent physical correlates to represent DNA –
such as ﬂuorescent light for Illumina and PacBio, change in acidity for Ion Torrent,
and change in current for NanoPore – the systematic errors will likely be diﬀer-
ent too. Moreover, their measurement procedures are also diﬀerent; some observe
nucleotides one by one, some in stretches or in sliding 5-nucleotide k-mers. As dis-
cussed in chapter 5 there is even a concordance between multiplex TLA-based NGS
and microscopy-based karyotyping for the detection of chromosomal translocations.
In other words, these techniques take diﬀerent perspectives on the DNA and for
large parts of the genome the statement holds that DNA sequence “looks the same
from here and from there”.
Studies such as the Genome In A Bottle (GIAB) consortium show that a high
percentage of SNVs and indels are called using diﬀerent measurement methods
[443] and, as we have seen in this thesis, there is a concordance between NGS and
Sanger for SNP and indel calling, between NGS and MLPA or array for CNV calling,
and between NGS, FISH and karyotyping for translocations and trisomies. Moreover,
predictions for protein amino acid change by speciﬁc DNA variants match the protein
measurement results – although diﬀerences are also observed, for which RNA/protein
editing mechanisms are hypothesized [426]. Furthermore, actual human-observable
eﬀects are present in exon-skipping that overcomes the eﬀect of a DNA mutation to
rescue protein function. This can result, for instance, in improved muscle function
that is humanly observable through faster running times [245]. Further support
for the adequacy of NGS measurement outcomes as a representation of the DNA
sequence is that detected variants are in concordance with the laws of segregation.
In trio analysis – father, mother and child – most variants found in the child are also
detected in one or both of the parents [113].
Van Fraassen describes empirical facts as:
the very stability in the procedures found in [...] historical development, and
the reliability of the predictions concerning these and their correlation with
other measurement procedures derived from the mature theory in which they
are now theoretically embedded. [p.124]
In my opinion DNA variation detection passes this deﬁnition, which would mean
that DNA sequences, and variation therein, can be considered as empirical facts if
we adhere to this constructive empiricist deﬁnition.
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9.1. PERSPECTIVES AND MEASUREMENTS
BOX 1 Abstracted workﬂow of variant detection using Illumina
Sequencing-By-Synthesis capturing based WES experiment,
based on white blood cells
A. DNA isolation
1. Extraction of a tube of blood from a person
2. Cell lysis




6. Sequence adapter attachment
7. DNA fragment size selection
8. PCR enrichment of DNA fragments with adapters on both ends
9. Capturing of exonic regions using DNA- or RNA-baits complementary
to sequences of interest
10. PCR enrichment of captured DNA fragments (using barcodes for
sample multiplexing)
C. Sequencing
11. Attachment of adapter-ligated DNA fragments to the sequencing
ﬂow-cell
12. Cluster formation by bridge-ampliﬁcation of the attached DNA
fragments
13. Sequencing-by-synthesis using ﬂuorescent labelled nucleotides
(A, C, G, T) and cameras
D. Data processing
14. Creation of sequence reads by combining measured ﬂuorescent
signal intensities per coordinate over all cycles
15. Alignment of short reads against a reference genome to create
consensus genome
16. Detection of diﬀerences between the consensus and the reference
genome
However, representation does not necessarily equal accurate representation [262].
For instance, the GIAB consortium have labelled variants high conﬁdence or low
conﬁdence. This means that for some of the variants there is a higher chance
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CHAPTER 9. WHAT CAN I KNOW?
of them not representing the DNA sequence accurately, for instance if analyses
using diﬀerent platforms or duplicate analyses on the same platform disagree on the
nucleotide present on a speciﬁc location. In most laboratories DNA analysis is done
using a single run on a single platform, leading to fewer possibilities to distinguish
high and low conﬁdence calls based on the data itself. Quality metrics (base quality,
mapping quality, and genotype quality) only tell a part of the story, since only the
quality from the sequencer onwards is taken into account. This does not need to be a
problem so long as the strengths and weaknesses of the technique and bioinformatics
analysis used are understood.
9.2 Assumptions and biases in next-generation
sequencing
In this section I want to focus on the noise that stands between the ﬁnal analysis
outcome and the DNA sequence that we are trying to determine. In total, we
can distinguish four types of such noise: A. biological noise, B. laboratory-induced
noise, C. sequencing noise and D. data analysis noise. Each category can be further
subdivided into concrete issues that have to be overcome to obtain a representation
that can be considered as accurate as possible. As an example of the noise present
in sequencing procedures, I want to use an abstracted workﬂow for an Illumina
Sequencing-By-Synthesis capturing-based WES experiment based on white blood
cells (BOX 1).
The exact issues diﬀer per procedure used, but similar procedures will have com-
parable biases. The categories A-D are connected to the four noise types, although
DNA isolation and sequencing can also be considered as laboratory techniques. Each
of the four blocks described have their own propositions for the ideal world, but var-
ious types of errors/bias can occur to obscure the accuracy of the representation
(BOX 2).
In the remainder of this section, the sources of noise in the four categories are
described in more detail.
A. White blood cells will generally yield good quality DNA, but other materials,
such as bone-marrow cells or FFPE material, can result in low quality or degraded
DNA. Furthermore, the DNA bases in materials that have been stored for a long
period can change over time, resulting in an increasing number of false positive
SNV calls [139]. In analysis of cell-free DNA (cfDNA) or circulating tumor DNA
(ctDNA) using blood plasma, white blood cells have to be stabilized or removed
quickly to prevent dilution with wild-type genomic DNA, which could cause false
negative results [237]. An issue arises in analyses of mixed DNA from diﬀerent
cell populations, such as tumor-normal or fetus-mother, because the normal and
maternal DNA can impede detection of variants in the tumor of fetal DNA. Moreover,
in NIPT, maternal variants, most notably microdeletions and monosomy X, can
cause false positive results [233, 307].
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9.2. ASSUMPTIONS AND BIASES IN NGS
BOX 2 Assumptions and forms of bias in next-generation sequencing
Category Assumptions ideal world Forms of bias
A. Biology The complete DNA of - Presence of other
interestis isolated as high- DNA (transplantation
molecular DNA, without any donor or maternal)
contaminants present, and - Degraded DNA
is representative of the - Presence of storage-
tested person’s DNA induced mutations
sequence.
B. Laboratory All sequences of interest - PCR eﬃciency
are evenly present, (GC bias)
represented by one - Imperfect capturing
instance per original eﬃciency
DNA fragment, without - Duplicate reads
oﬀ-target sequences, and - Run-to-run
ready for sequencing. diﬀerences
C. Sequencing All sequences of interest - Run-to-run/
result in clear ﬂuorescent lane-to-lane
signals at the correct diﬀerences
position, without inter- - Phasing error
ference of other signals - Error by motif
D. Data analysis D1. Sequence of the DNA - Wrongly inferred
fragment is correctly intensity
inferred.
D2. Reference genome has - Inadequate
a close match in sequence reference sequence
to my sample of interest. for the person analyzed
D3. The short-read sequences - Low mappability
can be correctly and
uniquely placed onto
the reference genome.
D4. The diﬀerences between - Diﬃcult
consensus and reference variant types
















CHAPTER 9. WHAT CAN I KNOW?
B. After sample preparation, the samples will be ready for sequencing. How-
ever, as we have seen in chapters 2 and 3 and other studies [315], the coverage in
targeted NGS is not evenly distributed between captured regions (mainly based on
GC percentage), capturing eﬃciency is not perfect and PCR causes duplicate reads
[148]. In cases where too few reads are captured for a speciﬁc region, false negative
results can occur. Furthermore, PCR procedures that cause uneven distribution can
even induce higher false positive rates at higher coverages [401]. The severity of
this bias diﬀers between sequencing runs. In WGS, no capturing is needed, leaving
one fewer source for bias, and this is also the case in the PacBio procedure, which
has an ampliﬁcation-free procedure [301]. In general, a higher library complexity
will result in less bias [148]. Yet duplicate reads can also be used to our advantage.
One often-used strategy is to use Unique Molecule Identiﬁers, or UMIs. These can
be used to identify duplicate reads, thus reducing the number of duplicate reads
while also increasing the quality of base-calls within the read, solving some of the
C/D1 issues [348]. With UMIs, the higher the number of duplicate reads, the higher
the base quality. This is especially important when you are interested in somatic
variants that are only present in a small percentage of sequenced DNA (or RNA)
fragments. However, even when collapsing all duplicate reads into one, or removing
all but one of these sequences, coverage bias is present from sample to sample,
hampering comparison between samples.
C. In Illumina sequencing (as well as with other platforms) errors can occur
during sequencing due to a failure to identify (ﬂuorescent) signals correctly. These
errors can diﬀer from run to run and from lane to lane [3]. Often, errors occur
at homopolymers, where the number of nucleotides present is determined incor-
rectly due to incorrect phasing in Illumina sequencing, or small diﬀerences in signal
intensity in SOLiD or IonTorrent technologies. In Illumina sequencing, there is a no-
table diﬀerence between the 4-channel sequencing (Miseq, Hiseq) and the 2-channel
chemistry (NextSeq500, NovaSeq, MiniSeq), with the latter being much more prone
to wrong base identiﬁcation [10]. In addition, several sequence motifs (speciﬁc base
composition categories) have been associated with sequencing bias [315].
D1. It is debatable whether misidentiﬁcation of the sequence from data is
caused by unclear ﬂuorescent signals, or by the failure to correctly infer the fragment
sequence. For all platforms, the assignment of a speciﬁc base to a position in the read
is a prediction, with a reliability represented by the quality scores. For Illumina Phred
based scores, these are calibrated using a large set of known sequences. Based on this
empirical evidence, base quality scores are calculated for new, unknown, sequences
[159]. However, these probabilities only hold true as far as the sequencing process
itself. Changes in sequence introduced during steps A to C are really present during
the sequencing process and, even if correctly inferred, are still not representative of
the tested individual’s DNA sequence.
D2. For short-read Illumina sequencing, a reference genome is most often used.
The exact sequence between genome builds has changed over the years [331], and for
some more diﬃcult to sequence regions, the sequence has changed dramatically. For
the interpretation of an individual’s genomic sequence, this means that the placement
of sequenced reads can diﬀer from build to build. Some highly variable regions have
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9.2. ASSUMPTIONS AND BIASES IN NGS
several contigs that each represent a possible reference sequence. Furthermore,
repetitive elements, such as Alu repeats, make up a large part of the genome. Nor is
a correct reference genome always available for those sequences [416]. In addition,
because individuals diﬀer, no reference genome is perfect for all individuals, leading to
possible misinterpretation. For instance, it is known that 0.26% of the population has
a SMAD4 pseudogene [243]. Because this pseudogene is not present in the general
reference, reads from SMAD4 pseudogene DNA fragments will map to SMAD4 with
high mapping quality and can seemingly result in a high-quality SMAD4 variant call.
Alternatively, de novo assembly can be used as an assumption-free strategy to infer
the most likely genomic sequence. However, when using short read sequencing,
only short contigs can be created, making this strategy impractical. For long-read
sequencing, as discussed in the ﬁnal part of this discussion, this may be a viable
option.
D3. Even when a correct reference sequence is present for a genomic sequence,
we’re not out of the woods. It has been estimated that approximately half to two
thirds of the human genome is repetitive in nature [83], meaning these areas are
prevalent around the genome. For instance, if sequenced fragments are around 250
bp long, a non-unique sequence over 500 bp length will have an ‘unmappable’ region
in the middle. Thus, many reads can map onto diﬀerent locations of the reference
genome, either in non-coding sequences, homologous genes, pseudogenes, or within
the same gene [228]. Some of those locations are located within coding sequences
of genes that have a clear association with hereditary disease. Notably, four of
the genes mentioned, MYH6, MYH7, TTN and PMS2, are included in our gene
panels related cardiomyopathy/pulmonary arterial hypertension and familial cancer
gene panels as discussed in chapters 2 to 4. When the perspective is changed by
using longer reads, a larger part of the genome will be covered uniquely, as will be
discussed in chapter 11.
D4. The bias introduced during the previous steps results in a second issue. Can
the correct DNA sequence be inferred? Even though alignment and variant calling
procedures have developed further since we established the procedure described in
chapter 2, recent research has shown that variants in non-unique regions, as well
as some types of variants such as indels of around 100 bp and variants in tandem
repeats, are often still not detected by short-read sequencing [213]. The same
data may give diﬀerent sensitivity and speciﬁcity for diﬀerent types of variants.
For instance, sensitivity to detect SNVs is generally higher than for indel detection
[103]. Because a diﬀerent analysis perspective is taken on the data produced –
using read depth rather than base diﬀerences from the reference genome – CNV and
translocation detection (as described in this thesis) provide a completely diﬀerent
representation of the human genome than SNV and indel detection. Because the
noise aﬀects diﬀerent types of analyses diﬀerently, a single dataset can be of suﬃcient
quality for detection of one type of variant, but of low quality for detection of another
type. Moreover, the detection of each possible speciﬁc variant has its own sensitivity
and speciﬁcity that is related both to the general characteristics of the assay and
to the performance of the speciﬁc test performed, which may have more noise to
obscure the variant of interest or less noise making it more easily visible. To identify
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CHAPTER 9. WHAT CAN I KNOW?
regions and variants that are more (or less) reliable for variant calling, most tools
include quality metrics, such as base quality, mapping quality, coeﬃcients of variance
and genotype quality that try to provide information regarding sample-speciﬁc and
genomic-position-speciﬁc quality and, as such, the predictive value of called or non-
called variants. Following the recommendations of the Genome Analysis Tool Kit
(GATK), low mapping quality for the unmappable regions result in low MAPQ scores
that will result in fewer reads used for variant calling [160]. Unfortunately, this means
that these regions are indeed ‘dead zones’, using the terminology of Mandelker et al.
[228]. In practice the called variants are not so problematic. Their presence can be
conﬁrmed by another technique and a well-advised conclusion can be made. Genomic
positions without a variant call are often more problematic. The assumption is that
if no call is present, the sample sequence matches the reference. But this is not
necessarily true. There may also be insuﬃcient power for a variant call, or the test
may even have failed for the speciﬁc region of interest. It is therefore important to
provide quality information on each prediction, even for a position that is predicted
to be ‘normal’. For SNV analysis and short indels, such information is present, but
in NGS, CNV callers often give quality information of positive results only.
A third issue arises when a statistical test is used for variant prediction, such as
in CNV detection and NIPT, even when no bias is present. As discussed in chapter
8, the prevalence of the variant of interest in the population will aﬀect the positive
predictive value of the analysis. When a speciﬁc variant of interest has diﬀerent
prevalences in two populations, a test with the same sensitivity and speciﬁcity will
have diﬀerent predictive values for each population.
Therefore, all variant calling based on a single sequencing technique, using a
single perspective, should be approached with caution. When interpreting NGS DNA
sequencing results for known diﬃcult regions, technicians, laboratory specialists and
researchers should not forget that we don’t live in the ideal world and that biases
are present, even if we have tried to look through all the noise. Nonetheless, NGS
is a reliable technique in general. In practice, sensitivity and speciﬁcity are high
for a large part of the analyzed data, at least when comparing results with other
techniques that take diﬀerent perspectives.
From a more philosophical view, we can now come to a more clear view of the
term ‘noise’ that is so prominent in the title of this thesis. In general, we can deﬁne
noise as everything that, from a certain perspective, blocks the path between reality
and measurement outcome. In sequencing, everything that has a negative eﬀect on
the truth-value of a proposed sequence for a speciﬁc individual is noise. As we have
seen, we can distinguish four types of such noise: A. biological noise, B. laboratory
induced noise, C. sequencing noise and D. data analysis noise.
9.3 From genotype to phenotype
Now that we have determined to what extent NGS can give an accurate represen-
tation of the DNA sequence, we can take a look at what variation in this sequence
actually means. The noise does not stop at the moment a DNA variant is detected,
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9.3. FROM GENOTYPE TO PHENOTYPE
and we can add a fourth layer to the question ‘what can we know?’.
Can we know what a DNA variant means with regard to the phenotype? Ac-
cording to C. Kenneth Waters (2007) DNA is the ‘speciﬁc actual diﬀerence maker’
(SAD) [407]. For Waters, “to be the actual diﬀerence making cause of an actual
diﬀerence in a population, the value of the variable must actually diﬀer and this vari-
ation must bring about the actual diﬀerences among the entities in the population”
[407][p.17]. DNA works in conjunction with a network of other molecules that are
also causes, but (variation in the) DNA is the root cause of actual diﬀerences in the
end. Diﬀerences in DNA sequence ﬁrst result in diﬀerences in the RNA sequences
produced and then, if the DNA is protein coding, often in diﬀerences in amino acid
sequences. Waters states that there are other SADs, such as splicing agents, but
these are not on par with DNA.
This framework in which single DNA variants cause actual diﬀerences between
individuals seems to ﬁt nicely with the classical monogenic, Mendelian, heredity
framework. A ﬁve-class system – labeling variants Benign, Likely Benign, Variant
of Unknown Signiﬁcance (VUS), Likely Pathogenic or Pathogenic – is the current
standard for reporting the clinical interpretation of these variants [308]. But is it wise
to force all DNA variants into a framework that labels every single variant by itself
without regard for further genomic context? In contrast, and still in line with the
interpretation of DNA as the SAD, are genetic risk scores [175, 429]. These predict
the risk of developing a certain phenotype based not on a single DNA variant, but on
a group of variants, and help with strategies to predict the development of complex
disease. Many variants considered to be pathogenic are not fully penetrant and, as is
already incorporated in the term ‘risk score’, not all people carrying speciﬁc variants
will develop a given phenotype. Griﬃtz and Stotz argue that environment plays a
more important role in the development of a phenotype than the SAD framework
allows [136][p81/p199]. Other genes and (regulatory) variants and environmental
factors can be an explanation for the variations in penetrance level of pathogenic
variants. These so-called ‘potential diﬀerence makers’ discussed by Waters and
Griﬃtz & Stotz may explain why one person does develop a disease, while another
with the same DNA variant does not. Illuminating these factors is important if we
want to know what carrying a speciﬁc DNA variant will mean for a speciﬁc person,
and will form a further step towards personalized medicine.
It seems then, from the perspective of hereditary disorders, that DNA variants
can be considered as SADs that have predictive value for disease risk or prognosis.
However, the question of penetrance remains. The answer regarding penetrance
of variants in causing a disease will partly lie in a more complex genetic proﬁle
explaining the disease risk, instead of a mutation in a single gene. A further part
of the explanation will lie in a diﬀerence of environment, which will or will not
trigger potential diﬀerence makers. For instance alcohol consumption, malnutrition
and smoking during pregnancy can induce epigenetic changes in the unborn child
that alter neurodevelopmental processes [297, 22]. Because of these environmental
stimuli that enhance or silence gene expression, the child can develop a congenital
disorder. One of the big challenges for clinical genetics is not only to detect genetic
variants, but to also understand their eﬀect on the phenotype in context of each
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CHAPTER 9. WHAT CAN I KNOW?
other and of the environment, creating a clearer picture of the clinical relevance of
each person’s genetic proﬁle.
9.4 Conclusion
In this section I have identiﬁed four diﬀerent discussions related to the question
‘What can I know?’
1. What can I know about the origin of DNA variations? (e.g. placental or fetal)
2. What can I know about the DNA sequence based on NGS measurements?
3. What can I know about the predictive value of a statistical test for a particular
variant to be present in a particular individual?
4. What can I know about the relation between genotype and phenotype?
By no means do I claim I have provided the full scope of answers to these questions,
if this was even possible. However, if this reﬂection has planted a few seeds in the
heads of the readers regarding the assumptions that are made during analysis of
DNA measurement data and what we are actually analyzing, the purpose of this
reﬂection is met. Moreover, not knowing everything does not need to be problem-
atic. As long as you acknowledge that a measurement is performed from a speciﬁc
perspective (i.e. the methods and techniques used) and is aﬀected by several types
of noise, the representation of the DNA or chromosomes of the tested person can
be as accurate as possible. Despite that, knowing the assumptions and biases of
used methods and techniques is no guarantee for reaching the correct interpretation
of the measurement data regarding what it represents. The chance of obtaining an
accurate representation is higher when measurements and analyses are performed
from diﬀerent perspectives. Therefore, this reﬂection can be used as a philosoph-
ical basis for performing conﬁrmatory tests for detected variants, using a diﬀerent
method.
This being said, we can continue our struggle to understand the nature of the
data we produce, the perspective that was used and the bias that was produced,
all of which creates the noise between the unobservable DNA and the observable
measurement outcomes. The ultimate goal is to get as close as possible to an
accurate representation, closer to the ideal world, in which noise is cancelled out or
corrected for and empirical adequacy aligns perfectly with reality. Although, even if
we did get there, we could never know for sure.
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